Table of Contents
Who is Clovis Oncology?
Founded in 2009, Clovis Oncology ( NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Development Programs Are Focused on Providing the Right Drug, to the Right Patient at the Right Time
What are Clovis’ product development programs?
Clovis’ product development programs generally target specific subsets of cancer, and the Company seeks to simultaneously develop, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use.
What is Salesforce for Life Sciences?
Optimized to handle the industry’s unique and fast-paced needs, Salesforce for Life Sciences helps medical device and pharmaceutical companies collaborate across entire ecosystems, get new products into market faster, turn valuable data into actionable insights, and revolutionize patient care. Connecting every point along the path to better health.
How has Clovis stock performed year to date?
Clovis’s stock has advanced 10.8% year to date through Thursday, while the iShares Nasdaq Biotechnology ETF IBB, +3.87% has tacked on 1.2% and the S&P 500 SPX, +2.09% has gained 4.2%.
Who owns krystexxa?
Krystexxa is already far ahead of where it had been when Horizon agreed to acquire owner Crealta—which had snatched the med from bankrupt developer Savient—in December 2015 and started shifting Krystexxa toward patients with more severe and treatment-resistant gout.
What percentage of TV news ads are pharmaceutical?
75 percentIn 2020, the pharmaceutical industry spent 4.58 billion U.S. dollars on advertising on national TV in the United States, unsurprisingly representing a big shift in spending compared to the 2019 pre-covid market. In 2020 TV ad spending of the pharma industry accounted for 75 percent of the total ad spend.
Which is the biggest component of pharma marketing expenditure?
Pharma TV advertising remained the cornerstone of spending with $4.58 billion, a whopping 75% of the total spend. That’s up just slightly from 2019 when national TV was 73% of pharma’s investment.
Does Big pharma spend more on advertising than research?
Overhead Advertising and Corporate Overhead Outweigh R&D: A 2019 study from the Campaign for Sustainable Rx Pricing (CSRxP) found Big Pharma spends more than twice as much on corporate overhead and advertising as it does on R&D.
How many pharmaceutical ads are on TV?
Bell writes, “The numbers behind those decisions are quite staggering. Just considering television, 187 commercials for about 70 prescription medications have collectively aired almost half a million times since the start of 2018.
Why are there so many pharmaceutical commercials on TV?
Pharmaceutical Research and Manufacturers of America, an industry group, says direct-to-consumer ads are “designed to provide scientifically accurate information to patients so that they are better informed about their healthcare and treatment options.”
How big is the pharmaceutical market?
Report Overview. The global pharmaceutical manufacturing market size was valued at USD 405.52 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.34% from 2021 to 2028.
What are 4p in pharmaceutical marketing systems?
The pharmaceutical marketing mix first introduced by Borden in 1964 with the basic elements are the product, price, place, and promotion (collectively coined the 4Ps of marketing) [2].
How much do pharmaceutical marketers make?
Salary Ranges for Pharmaceutical Marketings The salaries of Pharmaceutical Marketings in the US range from $17,979 to $474,242 , with a median salary of $86,622 . The middle 57% of Pharmaceutical Marketings makes between $86,629 and $215,717, with the top 86% making $474,242.
Which entities invests the most money in pharmaceutical R&D?
Pharmaceutical Companies Pharmaceutical firms represent a large investor in overall health R&D. In 2016, they spent $156.7 billion globally. Roche and Novartis were the largest investors in this space, spending $8.7 billion and $7.9 billion, respectively.
How much does Pfizer spend on research?
Pfizer annual research and development expenses for 2021 were $13.829B, a 47.23% increase from 2020. Pfizer annual research and development expenses for 2020 were $9.393B, a 12.02% increase from 2019. Pfizer annual research and development expenses for 2019 were $8.385B, a 8.05% increase from 2018.
How much does Big pharma spend on R&D?
In 2019, the pharmaceutical industry spent $83 billion dollars on R&D.
2. What does Salesforce do?
Bet Astro wishes they had a nickel for every time this question came up. The company has evolved and grown so much since it was founded in 1999 — and as its size and scope have increased, so has the complexity of this answer.
3. How much information does Salesforce process in 24 hours?
Salesforce brings companies and customers together. In other words, it powers trillions of business-to-business (B2B) and business-to-consumer (B2C) interactions.
5. Where does Salesforce operate around the world?
Salesforce operates in 84 cities, with 110 offices around the world. There are eight Salesforce Towers currently (in Atlanta, Dublin, Indianapolis, London, New York, Paris, San Francisco, and Tokyo) with another two in development (Salesforce Tower Sydney and Salesforce Tower Chicago).
6. How tall is the Salesforce tower in San Francisco?
1,070 feet. Opened in 2018, the Salesforce Tower in San Francisco is 61 stories and 1.4 million square feet of office space.
7. How diverse is Salesforce?
Last year, Salesforce set a goal to have 50% of its U.S. employees from underrepresented groups (Women, Black, Latinx, Indigenous, Multiracial, LGBTQ+ employees, People with Disabilities, and Veterans)by 2023.
8. How much has Salesforce spent to ensure equality in employee salaries?
Salesforce has spent $16 million to date to ensure equal pay for equal work among its global workforce. In 2015, the company committed to investigating and addressing any gender pay gaps.
9. How is Salesforce a sustainable company?
In 2021, Salesforce achieved net zero across its full value chain and reached 100% renewable energy. This means Salesforce has purchased enough renewable energy to match all electricity it uses globally.
About
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments.
Highlights
View contacts for Clovis Oncology to access new leads and connect with decision-makers.
Details
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Accelerate R&D Innovation
Transform therapy development with a holistic view of trials. Reduce time to market by integrating systems and teams on a single, secure platform and accessing real-time data on any device. Strengthen patient recruitment and retention with personalized communication tools.
Connect Patient Experience
Enhance patient programs while reducing operational costs. Get patients on therapy faster by delivering therapeutic-specific support programs at scale, creating connected personalized experiences, and tracking performance with built-in analytics and AI.
Patient Management Software from Salesforce
Patient relationship management software by Salesforce gives you a platform to transform healthcare by creating stronger relationships between patients, payers, and providers. The CRM software offers you tools to see patient status and progress more clearly and better share information amongst the caregiving team.
Patient Management Software from Salesforce
Patient relationship management software by Salesforce gives you a platform to transform healthcare by creating stronger relationships between patients, payers, and providers. The CRM software offers you tools to see patient status and progress more clearly and better share information amongst the caregiving team.
Build trusted member relationships
Drive efficiencies throughout the entire enterprise to streamline collaboration and personalize members’ health journey across all touchpoints.
Deliver patient-centered experiences
Gain a 360-degree view of patients and teams with an interoperable HIPAA-compliant platform. Connect systems and teams to unlock new value from your data, streamline processes, and surface new opportunities for proactive engagement.
PHARMA
Make strategic decisions all year long with key learnings from holiday 2020.
What happened
Shares of Clovis Oncology ( CLVS 4.08% ) soared 48% on Friday after the biopharmaceutical company announced positive findings from its phase 3 study for its ovarian cancer drug, Rubraca.
So what
Data from the clinical trial showed Rubraca to significantly improve progression-free survival (PFS) compared to standard-of-care chemotherapy among patients with advanced, relapsed ovarian cancer and a specific gene variant, known as a deleterious BRCA mutation.
NASDAQ: CLVS
Clovis Oncology’s stock price surged on Friday. Image source: Getty Images.
Now what
More than 21,000 women will be diagnosed with ovarian cancer in the U.S. alone this year, according to the American Cancer Society. Worse still, nearly 14,000 of these women are likely to die from the disease. Rubraca could potentially give doctors another tool to combat this far-to-often deadly form of cancer.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool’s premium services.